Insiders Updates
An Analysis of ReShape Lifesciences Inc. (RSLS)’s Potential Price Growth
ReShape Lifesciences Inc.’s recent filing unveils that its Chief Financial Officer STANKOVICH THOMAS unloaded Company’s shares for reported $12.0 on
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.